Journal
Journal of Clinical Lipidology
Publication Date
5-1-2022
Volume
16
Issue
3
First Page
286
Last Page
297
Document Type
Open Access Publication
DOI
10.1016/j.jacl.2022.03.001
Rights and Permissions
Laufs U, Ballantyne CM, Banach M, Bays H, Catapano AL, Duell PB, Goldberg AC, Gotto AM, Leiter LA, Ray KK, Bloedon LT, MacDougall D, Zhang Y, Mancini GBJ. Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials. J Clin Lipidol. 2022 May-Jun;16(3):286-297. doi: 10.1016/j.jacl.2022.03.001. © 2022 National Lipid Association. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Recommended Citation
Laufs, Ulrich; Ballantyne, Christie M; Banach, Maciej; Bays, Harold; Catapano, Alberico L; Duell, P Barton; Goldberg, Anne C; Gotto, Antonio M; Leiter, Lawrence A; Ray, Kausik K; Bloedon, LeAnne T; MacDougall, Diane; Zhang, Yang; and Mancini, G B John, "Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials." Journal of Clinical Lipidology. 16, 3. 286 - 297. (2022).
https://digitalcommons.wustl.edu/oa_4/1331
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
